The Defense Health Agency (DHA) awarded a $249,837.63 Small Business Technology Transfer (STTR) Phase I contract to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is for the development of an automated detection platform for circulating and exosomal microRNAs, with potential applications in early disease detection and precision medicine. This contract is part of the DHA's research and development efforts in advanced diagnostic and biosensor technologies. Emergingdx Inc. has received multiple federal contract and grant awards from defense and civilian agencies, including the Office of Naval Research and the Department of Agriculture, to support its work in developing innovative diagnostic solutions.
Generated 12/20/24, 9:11 AM